BMC CANCER, cilt.5, 2005 (SCI-Expanded)
Background: The purpose of our study was to investigate the immunohistochemical expression of TGF-beta 1 and p27 in pancreatic adenocarcinomas and to compare the findings with the clinicopathological features and survival. We also aimed to evaluate the expression of TGF-beta 1 and p27 in the context of other cell cycle and proliferation markers such as cyclin D1 and Ki-67.